Report Code: A13347 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cough Suppressant Drugs Market
Request Now !Cough is a sudden expulsion of air through breathing passage that helps to clear mucous or fluids, foreign particles, and microbes. It is a protective reflex action and can be repetitive. Frequent coughing indicates presence of any irritation or disease. Choking, smoking, air pollution, asthama, bacterial infection, chronic bronchitis, lung tumors, and others can be the causes of cough. Cough can be divided into acute cough and chronic cough. Cough suppressants inhibit coughing and irritation in throat. Dextromethorphan, salbutamol, inhaled corticosteroids, and benzonatate are the some drugs which can be used as cough suppressants.
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the cough suppressant drugs market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2021, Ernest Chemists announced launch of new herbal cough remedy named as Honeykof. This product use in treatment of throat infection and reduce amount of cough.
In 2018, Perrigo Company Plc, announced FDA approval for launch of its OTC brand Mucinex DM Maximum Strength. This product use to reduce repetitive cough and break up mucus.
Key Benefits of the Report
Questions Answered in the Cough Suppressant Drugs Market Report    Â
Cough Suppressant Drugs Market Report Highlights
Aspects | Details |
---|---|
By Indication |
|
By Drug Type |
|
By Dosage Form |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Acella Pharmaceuticals LLC, Taro Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd, GlaxoSmithKline plc., Vernalis plc,, Perrigo Company plc, Aytu BioScience, Inc., Pfizer Inc., Mayne Pharma Inc., Amneal Pharmaceuticals LLC |
Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers